Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity.
about
Hypoxic regulation of osteoclast differentiation and bone resorption activityInvolvement of Prolyl Hydroxylase Domain Protein in the Rosiglitazone-Induced Suppression of Osteoblast DifferentiationOxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.Single-dose local simvastatin injection improves implant fixation via increased angiogenesis and bone formation in an ovariectomized rat modelHypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2.Hypoxia mimetic deferoxamine influences the expression of histone acetylation- and DNA methylation-associated genes in osteoblasts.The role of vasculature in bone development, regeneration and proper systemic functioning.Comparison of tissue processing methods for microvascular visualization in axolotls.Oral delivery of prolyl hydroxylase inhibitor: AKB-4924 promotes localized mucosal healing in a mouse model of colitis.Recruitment of osteogenic cells to bone formation sites during development and fracture repair.Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin.Epigenetic enzymes influenced by oxidative stress and hypoxia mimetic in osteoblasts are differentially expressed in patients with osteoporosis and osteoarthritis
P2860
Q28066276-65891683-E5A6-4A2B-9FC4-7399331FFD3DQ28548626-EBEFE5EC-CE04-4C3E-A9D4-7A9105EF3703Q35486453-48929D95-912D-49CF-939C-585C207A65A4Q35663884-F414DAEF-78D8-4B9A-9C42-943AD6C431E7Q38832911-F512EFAC-A27B-4420-8B0F-FB86F0E6DAD1Q38910456-80A38AF5-1909-49CA-934E-1A1160AF680DQ38963012-BCBC4DC7-0195-495B-A48A-2F9E297014F9Q41623764-E175C72D-241A-4C00-94B3-FC80399C7C10Q51022045-2F3DB6D8-E187-4351-B9E9-F7165FB0FE78Q51427640-15EAF3C7-27D0-4900-836B-A955CC0D772AQ51513431-AC398670-D073-4688-8689-72F66214636FQ55517542-688E187B-9D04-4DAA-B5EB-17FFF11CC364Q58577447-1F6D87DC-BD67-4716-AB78-185368259289
P2860
Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Prolyl hydroxylase inhibitors ...... y increasing bone vascularity.
@en
Prolyl hydroxylase inhibitors ...... y increasing bone vascularity.
@nl
type
label
Prolyl hydroxylase inhibitors ...... y increasing bone vascularity.
@en
Prolyl hydroxylase inhibitors ...... y increasing bone vascularity.
@nl
prefLabel
Prolyl hydroxylase inhibitors ...... y increasing bone vascularity.
@en
Prolyl hydroxylase inhibitors ...... y increasing bone vascularity.
@nl
P2093
P2860
P1476
Prolyl hydroxylase inhibitors ...... y increasing bone vascularity.
@en
P2093
P2860
P2888
P304
P356
10.1007/S12013-013-9780-8
P577
2014-05-01T00:00:00Z